Autoimmune hemolytic anemia in patients with systemic lupus erythematosus

American Journal of Medicine

Volumn 108, Issue 3, 2000, Pages 198-204

  Kokori, Styliani I G ^a   Ioannidis, John P A ^b,c   Voulgarelis, Michalis ^a   Tzioufas, Athanasios G ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANEMIA, HEMOLYTIC; ANTIBODIES, ANTICARDIOLIPIN; AUTOIMMUNITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; THROMBOSIS;

EID: 0033978350     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00413-1     Document Type: Article

References (23)

1. Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993;7:199-207.
2. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, et al. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus. 1993;2: 303-312.
3. Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med. 1977;86:220-229.
4. Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Correlation with anemia. Arthritis Rheum. 1997;40:2212-2216.
5. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus review of the literature and clinical analysis of 138 cases. Medicine. 1954;33:291-437.
6. Nossent JC, Swaak AJG. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. QJM. 1991;80:605-612.
7. Worlledge S. Immune haemolytic anaemias. In: Hardisty RM, Weatherall DJ, eds. Blood and Its Disorders. Oxford: Blackwell Scientific Publications, 1982:479-513.
8. Alger M, Alargon-Segovia D, Riveroa SJ. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol. 1977;4:351-357.
9. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med. 1996;156:1337-1344.
10. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine. 1989;68:353-365.
11. Deleze M, Alargon-Segovia D, Oria CV, et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol. 1989;16:926-930.
12. Harris NE, Phil M, Chan JKH, et al. Thrombosis, recurrent fetal loss, and thrombocytopenia. Arch Intern Med. 1986;146:2153-2156.
13. Drenkard C, Villa AR, Alargon-Segovia D, Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol. 1994;21:1067-1072.
14. Tan EM, Cohen AS, Fries JF, et al. The revised criteria for the clas-sification of systemic lupus erythematosus. Arthritis Rheum. 1982; 1982:25:1271-1277.
15. Tzioufas AG, Manoussakis MN, Drosos AA, et al. Enzyme immunoassays for the detection of IgG and IgM anti-ds DNA antibodies: clinical significance and specificity. Clin Exp Rheumatol. 1987;5: 247-253.
16. Vlachoyiannopoulos PG, Petrovas C, Tektonidou M, et al. Antibodies to β2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis. J Clin Immunol. 1998;18:380-391.
17. Vitali C, Bencivelli W, Isenberg DA, et al, and the European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol. 1992;10:541-547.
18. Bencivelli W, Vitali C, Isenberg DA, et al, and the European Consensus Study Group of the European Workshop for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol. 1992;10:549-554.
19. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure-time Data. New York: Wiley, 1980.
20. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. 2: The Analysis of Case-control Studies. Lyon: IARC Press, 1984.
21. Engelfriet CP, Overbeeke MAM, von dem Borne AEGKr. Autoimmune hemolytic anemia. Semin Haematol. 1992;29:3-12.
22. Lopez-Soto A, Cervera R, Font J, et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol. 1997;15:143-149.
23. Sthoeger Z, Sthoeger D, Green L, Geltner D. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. J Rheumatol. 1993;20: 2058-2061.